BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2022974)

  • 21. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
    Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
    Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis.
    Segtnan EA; Grupe P; Jarden JO; Gerke O; Ivanidze J; Christlieb SB; Constantinescu C; Pedersen JE; Houshmand S; Hess S; Zarei M; Gjedde A; Alavi A; Høilund-Carlsen PF
    J Nucl Med; 2017 May; 58(5):768-773. PubMed ID: 27789719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
    Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
    J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of glucose transport in malignant glioma by PET.
    Ishikawa M; Kikuchi H; Nishizawa S; Yonekura Y
    Acta Neurochir Suppl (Wien); 1990; 51():165-7. PubMed ID: 2089886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
    Rhodes CG; Wise RJ; Gibbs JM; Frackowiak RS; Hatazawa J; Palmer AJ; Thomas DG; Jones T
    Ann Neurol; 1983 Dec; 14(6):614-26. PubMed ID: 6606389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of survival in glioma patients by means of positron emission tomography.
    Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
    J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain imaging of glucose utilization in cerebral tumors.
    Di Chiro G
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():185-97. PubMed ID: 3875134
    [No Abstract]   [Full Text] [Related]  

  • 31. 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.
    Spence AM; Muzi M; Graham MM; O'Sullivan F; Link JM; Lewellen TK; Lewellen B; Freeman SD; Mankoff DA; Eary JF; Krohn KA
    Clin Cancer Res; 2002 Apr; 8(4):971-9. PubMed ID: 11948102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
    Newmark ME; Theodore WH; Sato S; De La Paz R; Patronas N; Brooks R; Jabbari B; Di Chiro G
    Arch Neurol; 1983 Oct; 40(10):607-10. PubMed ID: 6615267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
    Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.
    Otte A; Roelcke U; von Ammon K; Hausmann O; Maguire RP; Missimer J; Müller-Brand J; Radü EW; Leenders KL
    J Neurol Sci; 1998; 156(1):73-7. PubMed ID: 9559990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
    Voges J; Herholz K; Hölzer T; Würker M; Bauer B; Pietrzyk U; Treuer H; Schröder R; Sturm V; Heiss WD
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):129-35. PubMed ID: 9711745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
    Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
    No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
    Kim S; Chung JK; Im SH; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):52-9. PubMed ID: 15309332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
    Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.